194 related articles for article (PubMed ID: 16541479)
1. Evidence-based medicine is affordable: the cost-effectiveness of current compared with optimal treatment in rheumatoid and osteoarthritis.
Andrews G; Simonella L; Lapsley H; Sanderson K; March L
J Rheumatol; 2006 Apr; 33(4):671-80. PubMed ID: 16541479
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of current and optimal treatment for adult asthma.
Simonella L; Marks G; Sanderson K; Andrews G
Intern Med J; 2006 Apr; 36(4):244-50. PubMed ID: 16640742
[TBL] [Abstract][Full Text] [Related]
3. Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders.
Issakidis C; Sanderson K; Corry J; Andrews G; Lapsley H
Psychol Med; 2004 Jan; 34(1):19-35. PubMed ID: 14971624
[TBL] [Abstract][Full Text] [Related]
4. The burden of major depression avoidable by longer-term treatment strategies.
Vos T; Haby MM; Barendregt JJ; Kruijshaar M; Corry J; Andrews G
Arch Gen Psychiatry; 2004 Nov; 61(11):1097-103. PubMed ID: 15520357
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of infliximab (Remicade) in the treatment of ankylosing spondylitis in Canada.
Kobelt G; Andlin-Sobocki P; Maksymowych WP
J Rheumatol; 2006 Apr; 33(4):732-40. PubMed ID: 16583476
[TBL] [Abstract][Full Text] [Related]
6. The burden of rheumatoid arthritis and access to treatment: health burden and costs.
Lundkvist J; Kastäng F; Kobelt G
Eur J Health Econ; 2008 Jan; 8 Suppl 2():S49-60. PubMed ID: 18157732
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
Chisholm D;
Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443
[TBL] [Abstract][Full Text] [Related]
8. A clinical decision and economic analysis model of cancer pain management.
Abernethy AP; Samsa GP; Matchar DB
Am J Manag Care; 2003 Oct; 9(10):651-64. PubMed ID: 14572175
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC
Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based care for alcohol use disorders is affordable.
Corry J; Sanderson K; Issakidis C; Andrews G; Lapsley H
J Stud Alcohol; 2004 Jul; 65(4):521-9. PubMed ID: 15376827
[TBL] [Abstract][Full Text] [Related]
11. Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.
Dowdy DW; Sweat MD; Holtgrave DR
AIDS; 2006 Oct; 20(16):2091-8. PubMed ID: 17053355
[TBL] [Abstract][Full Text] [Related]
12. Global cost-effectiveness of cataract surgery.
Lansingh VC; Carter MJ; Martens M
Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
[TBL] [Abstract][Full Text] [Related]
13. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
[TBL] [Abstract][Full Text] [Related]
14. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of current and optimal treatment for schizophrenia.
Andrews G; Sanderson K; Corry J; Issakidis C; Lapsley H
Br J Psychiatry; 2003 Nov; 183():427-35; discussion 436. PubMed ID: 14594918
[TBL] [Abstract][Full Text] [Related]
16. Reducing the burden of affective disorders: is evidence-based health care affordable?
Sanderson K; Andrews G; Corry J; Lapsley H
J Affect Disord; 2003 Nov; 77(2):109-25. PubMed ID: 14607388
[TBL] [Abstract][Full Text] [Related]
17. The burden of rheumatoid arthritis: facts and figures.
Callahan LF
J Rheumatol Suppl; 1998 Jul; 53():8-12. PubMed ID: 9666412
[TBL] [Abstract][Full Text] [Related]
18. A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics.
Farahani P; Levine M; Goeree R
J Eval Clin Pract; 2006 Aug; 12(4):463-70. PubMed ID: 16907691
[TBL] [Abstract][Full Text] [Related]
19. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
[TBL] [Abstract][Full Text] [Related]
20. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
